Protagonist Therapeutics Inc (PTGX)
30.74
-1.20
(-3.76%)
USD |
NASDAQ |
May 17, 16:00
30.74
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Cash and Short Term Investments (Quarterly): 322.64M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 322.64M |
| December 31, 2023 | 341.62M |
| September 30, 2023 | 320.75M |
| June 30, 2023 | 313.40M |
| March 31, 2023 | 230.76M |
| December 31, 2022 | 237.36M |
| September 30, 2022 | 267.44M |
| June 30, 2022 | 291.89M |
| March 31, 2022 | 305.29M |
| December 31, 2021 | 326.90M |
| September 30, 2021 | 314.30M |
| June 30, 2021 | 354.28M |
| March 31, 2021 | 273.48M |
| December 31, 2020 | 305.81M |
| September 30, 2020 | 193.97M |
| June 30, 2020 | 208.66M |
| March 31, 2020 | 117.51M |
| Date | Value |
|---|---|
| December 31, 2019 | 133.02M |
| September 30, 2019 | 137.69M |
| June 30, 2019 | 126.10M |
| March 31, 2019 | 112.55M |
| December 31, 2018 | 128.85M |
| September 30, 2018 | 138.52M |
| June 30, 2018 | 125.17M |
| March 31, 2018 | 134.96M |
| December 31, 2017 | 144.00M |
| September 30, 2017 | 93.59M |
| June 30, 2017 | 64.49M |
| March 31, 2017 | 63.25M |
| December 31, 2016 | 77.60M |
| September 30, 2016 | 98.52M |
| June 30, 2016 | 20.18M |
| March 31, 2016 | 29.02M |
| December 31, 2015 | 11.92M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
117.51M
Minimum
Mar 2020
354.28M
Maximum
Jun 2021
256.14M
Average
282.68M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Lifecore Biomedical Inc | 19.09M |
| SELLAS Life Sciences Group Inc | 18.42M |
| Akebia Therapeutics Inc | 41.96M |
| Immuneering Corp | 71.28M |
| Moderna Inc | 8.523B |